Rajat Deo1, Yulia A Khodneva2, Michael G Shlipak3, Elsayed Z Soliman4, Suzanne E Judd5, William M McClellan6, Todd M Brown2, J David Rhodes7, Orlando M Gutiérrez2, Sanjiv J Shah8, Christine M Albert9, Monika M Safford10. 1. Electrophysiology Section, Division of Cardiovascular Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: Rajat.Deo@uphs.upenn.edu. 2. Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama. 3. Department of Epidemiology, Biostatistics, and Medicine, University of California San Francisco and Department of General Internal Medicine, San Francisco VA Medical Center, San Francisco, California. 4. Epidemiological Cardiology Research Center (EPICARE), Department of Epidemiology and Prevention, and Department of Internal Medicine, Cardiology Section, Wake Forest University School of Medicine, Winston Salem, North Carolina. 5. Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama. 6. Departments of Medicine and Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia. 7. Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama. 8. Division of Cardiovascular Medicine, Northwestern University, Chicago, Illinois. 9. Center for Arrhythmia Prevention, Division of Preventive Medicine, and Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. 10. Division of General Internal Medicine, Department of Medicine, Weill Cornell Medical College, New York, New York.
Abstract
BACKGROUND: Moderate-to-severe kidney disease increases risk for sudden cardiac death (SCD). Limited studies have evaluated how mild degrees of kidney dysfunction impact SCD risk. OBJECTIVE: The purpose of this study was to evaluate the association of albuminuria, which is one of the earliest biomarkers of kidney injury, and SCD. METHODS: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) study is a prospective, population-based cohort of U.S. adults. Associations between albuminuria, which is categorized using urinary albumin-to-creatinine ratio (ACR), estimated glomerular filtration rate (eGFR), and SCD were assessed independently and in combination. RESULTS: After median follow-up of 6.1 years, we identified 335 SCD events. Compared to participants with ACR <15 mg/g, those with higher levels had an elevated adjusted risk of SCD (ACR 15-30 mg/g, hazard ratio [HR] 1.53, 95% confidence interval [CI] 1.11-2.11; ACR >30 mg/g, HR 1.56, 95% CI 1.17-2.11). In contrast, compared to the group with eGFR >90 mL/min/1.73 m2, the adjusted risk of SCD was significantly elevated only among those with eGFR <45 mL/min/1.73 m2 (HR 1.66, 95% CI 1.06-2.58). The subgroup with eGFR <45 mL/min/1.73 m2 (n = 1003) comprised 3.7% of REGARDS, whereas ACR 15-30 mg/g (n = 3089 [11.3%]) and ACR >30 mg/g (n = 4040 [14.8%] were far more common. In the analysis that combined ACR and eGFR categories, albuminuria consistently identified individuals with eGFR ≥60 mLmin/1.73 m2 who were at significantly increased SCD risk. CONCLUSION: Low levels of kidney injury as measured by ACR predict an increase in SCD risk.
BACKGROUND: Moderate-to-severe kidney disease increases risk for sudden cardiac death (SCD). Limited studies have evaluated how mild degrees of kidney dysfunction impact SCD risk. OBJECTIVE: The purpose of this study was to evaluate the association of albuminuria, which is one of the earliest biomarkers of kidney injury, and SCD. METHODS: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) study is a prospective, population-based cohort of U.S. adults. Associations between albuminuria, which is categorized using urinary albumin-to-creatinine ratio (ACR), estimated glomerular filtration rate (eGFR), and SCD were assessed independently and in combination. RESULTS: After median follow-up of 6.1 years, we identified 335 SCD events. Compared to participants with ACR <15 mg/g, those with higher levels had an elevated adjusted risk of SCD (ACR 15-30 mg/g, hazard ratio [HR] 1.53, 95% confidence interval [CI] 1.11-2.11; ACR >30 mg/g, HR 1.56, 95% CI 1.17-2.11). In contrast, compared to the group with eGFR >90 mL/min/1.73 m2, the adjusted risk of SCD was significantly elevated only among those with eGFR <45 mL/min/1.73 m2 (HR 1.66, 95% CI 1.06-2.58). The subgroup with eGFR <45 mL/min/1.73 m2 (n = 1003) comprised 3.7% of REGARDS, whereas ACR 15-30 mg/g (n = 3089 [11.3%]) and ACR >30 mg/g (n = 4040 [14.8%] were far more common. In the analysis that combined ACR and eGFR categories, albuminuria consistently identified individuals with eGFR ≥60 mLmin/1.73 m2 who were at significantly increased SCD risk. CONCLUSION: Low levels of kidney injury as measured by ACR predict an increase in SCD risk.
Authors: Virginia J Howard; Robert F Woolson; Brent M Egan; Joyce S Nicholas; Robert J Adams; George Howard; Daniel T Lackland Journal: J Am Soc Hypertens Date: 2010 Jan-Feb
Authors: Virginia J Howard; Mary Cushman; Leavonne Pulley; Camilo R Gomez; Rodney C Go; Ronald J Prineas; Andra Graham; Claudia S Moy; George Howard Journal: Neuroepidemiology Date: 2005-06-29 Impact factor: 3.282
Authors: Carmen A Peralta; Michael G Shlipak; Suzanne Judd; Mary Cushman; William McClellan; Neil A Zakai; Monika M Safford; Xiao Zhang; Paul Muntner; David Warnock Journal: JAMA Date: 2011-04-11 Impact factor: 56.272
Authors: Rajat Deo; Nona Sotoodehnia; Ronit Katz; Mark J Sarnak; Linda F Fried; Michel Chonchol; Bryan Kestenbaum; Bruce M Psaty; David S Siscovick; Michael G Shlipak Journal: Circ Cardiovasc Qual Outcomes Date: 2010-01-19
Authors: Lesley A Inker; Christopher H Schmid; Hocine Tighiouart; John H Eckfeldt; Harold I Feldman; Tom Greene; John W Kusek; Jane Manzi; Frederick Van Lente; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey Journal: N Engl J Med Date: 2012-07-05 Impact factor: 91.245
Authors: Patrick M Pullicino; Leslie A McClure; Virginia G Wadley; Ali Ahmed; Virginia J Howard; George Howard; Monika M Safford Journal: Stroke Date: 2009-10-15 Impact factor: 7.914
Authors: Orlando M Gutiérrez; Yulia A Khodneva; Paul Muntner; Dana V Rizk; William M McClellan; Mary Cushman; David G Warnock; Monika M Safford Journal: JAMA Date: 2013-08-21 Impact factor: 56.272
Authors: Rajat Deo; Feng Lin; Eric Vittinghoff; Zian H Tseng; Stephen B Hulley; Michael G Shlipak Journal: Hypertension Date: 2008-04-07 Impact factor: 10.190
Authors: Nicole Redmond; Joshua Richman; Christopher M Gamboa; Michelle A Albert; Mario Sims; Raegan W Durant; Stephen P Glasser; Monika M Safford Journal: J Am Heart Assoc Date: 2013-12-19 Impact factor: 5.501
Authors: Esther D Kim; Elsayed Z Soliman; Josef Coresh; Kunihiro Matsushita; Lin Yee Chen Journal: J Am Soc Nephrol Date: 2021-01-28 Impact factor: 10.121
Authors: Oliver Darlington; Carissa Dickerson; Marc Evans; Phil McEwan; Elisabeth Sörstadius; Daniel Sugrue; Heleen van Haalen; Juan Jose Garcia Sanchez Journal: Adv Ther Date: 2021-01-11 Impact factor: 3.845
Authors: Lisandro D Colantonio; Richard J Reynolds; Tony R Merriman; Angelo Gaffo; Jasvinder A Singh; Timothy B Plante; Ninad S Chaudhary; Nicole D Armstrong; Elsayed Z Soliman; Jeffrey R Curtis; S Louis Bridges; Leslie Lang; George Howard; Monika M Safford; Kenneth G Saag; Paul Muntner; Marguerite Ryan Irvin Journal: J Rheumatol Date: 2021-06-15 Impact factor: 4.666